Navigation Links
PNAS Publishes Preclinical Results of EntreMed's 2ME2 for Multiple Sclerosis
Date:12/4/2012

ROCKVILLE, Md., Dec. 4, 2012 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that preclinical results for its compound 2-methoxyestradiol (2ME2) were published on line in this week's Early Edition of Proceedings of the National Academy of Sciences (PNAS).  The study was conducted at The Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital and was led by Tak W. Mak, Ph.D. 

(Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO )

Tak W. Mak, Ph.D., Director, The Campbell Family Cancer Research Institute, commented on the study, "Multiple sclerosis (MS) is among the most common autoimmune disorders in the northern hemisphere.  There exists significant unmet medical need for safe and effective drugs to treat MS.  In this study, we demonstrated that 2ME2, an endogenous metabolite of estradiol, significantly inhibits lymphocyte activation and proliferation and dramatically suppresses development of experimental MS.  Our analysis of cellular signaling pathways further reveals that 2ME2 exerts a potent inhibition of Nuclear Factor of Activated T cells (NFAT).  By extension, the study provides for the first time a molecular rational for the use of 2ME2 as a tolerable oral immunomodulatory agent for autoimmune disorders such as MS.  Other studies have shown that in humans, plasma levels of 2ME2 may increase dramatically during the last months of pregnancy, which intriguingly appears to correlate temporally with the remission of clinical symptoms reported in some pregnant MS and rheumatoid arthritis (RA) patients.  We believe that 2ME2 may offer a safe and effective treatment for such autoimmune disorders."

Ken Ren, Ph.D
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
2. Express Scripts Publishes Inaugural Drug Trend Quarterly, Provides First Comprehensive Overview of U.S. Prescription Drug Spending for 2012
3. Epizyme Publishes Current Review on Targeting Protein Methyltransferases for Personalized Cancer Therapeutics
4. Varian Medical Systems Publishes 2012 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
5. American Journal of Medicine Publishes Hypertension Study Comparing the Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone versus Azilsartan Medoxomil Co-administered with Hydrochlorothiazide
6. American Journal of Obstetrics and Gynecology Publishes PeriGen Research on Shoulder Dystocia
7. Pharmspective Publishes New Assessment of Impact of State Exchanges on Key Insurers and Pharma
8. Epilepsia Publishes Results From Two Studies Of Eisais Perampanel
9. Obesity journal publishes new study on lorcaserin, a weight-loss medication recommended for approval by FDA advisory panel
10. HemoShear Publishes Key Review on Human-Relevant Organotypic Systems
11. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... , June 29, 2015  PDL BioPharma, Inc. ... entered into a credit agreement with CareView Communications, Inc. ... to $40 million of secured debt financing. CareView is ... on patient care monitoring. Under the credit ... million of debt financing in two tranches of $20 ...
(Date:6/29/2015)... Minn. , June 29, 2015 EnteroMedics ... of devices that use neuroblocking technology to treat obesity, ... it has commenced an underwritten public offering of units. ... stock, Series A warrants to purchase common stock and ... purchase of units in the offering would result in ...
(Date:6/29/2015)... , June 29, 2015  Allergan plc ... intends to release second quarter 2015 financial results ... open of the U.S. financial markets. The Company will ... a.m. Eastern Daylight Time on Thursday, August 6, ... to access the call is U.S./ Canada ...
Breaking Medicine Technology:PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 2PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 4EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 2Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 3
... Radiologic (vRad), a technology-enabled national radiology practice, has again ... market segment by independent research and consulting firm KLAS. ... interviews conducted by KLAS and is published in the ... Software & Professional Services report. In ...
... Reportlinker.com announces that a new market research report ... Novo Nordisk A/S: PharmaVitae Profile ... This analysis examines the historical ... prescription pharmaceutical sector. The profile encompasses global company ...
Cached Medicine Technology:Virtual Radiologic Ranked #1 for Teleradiology Services for Third Consecutive Year 2Reportlinker Adds Novo Nordisk A/S: PharmaVitae Profile 2
(Date:6/30/2015)... ... June 30, 2015 , ... Bill Howe ... companies in San Diego. Bill Howe offers all employees ample opportunity for education ... but most notably through the local Plumbing-Heating-Cooling-Contractors of San Diego (PHCC-SD). The San ...
(Date:6/30/2015)... ... ... Intellitec Solutions has announced they will be hosting two webinars to answer ... and new procedures involved with updating the cloud version of Dynamics CRM, attendance is ... user interface and what it will mean for end users, critical items that need ...
(Date:6/30/2015)... ... June 30, 2015 , ... Americans report feeling more stressed than ever before. ... which puts stressed out people right over the edge. , Almost half of ... deprivation every night. Sleeping pills now lead the list of the most prescribed medications, ...
(Date:6/29/2015)... NY (PRWEB) , ... June 30, 2015 , ... ... honors Melanie Richards as a 2015-2016 inductee into its VIP Woman ... in business. NAPW is the nation’s leading networking organization exclusively for professional women, ...
(Date:6/29/2015)... , ... June 30, 2015 , ... Ticket Down is ... Soldier Field over the 4th of July weekend. Concertgoers can add promo/coupon code ... only recently caught on to their innovative sound, will not want to miss what ...
Breaking Medicine News(10 mins):Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 2Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 3Health News:Intellitec Solutions to Host Microsoft CRM 2015 Update Webinar 2Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 2Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 3Health News:National Association of Professional Women Inducts Melanie Richards, DMD, of Powdersville Pediatric Dentistry, Into its VIP Woman of the Year Circle 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Tickets Prices in Chicago at Soldier Field 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Tickets Prices in Chicago at Soldier Field 3
... heart expert calls it ,second-line, medication , , FRIDAY, ... the highly promoted cholesterol-lowering drug Vytorin continued Friday ... the medication,s effectiveness, but only after final trial ... this month when preliminary results of the so-called ...
... WellPoint, Inc. (NYSE:,WLP) announced today that senior ... Conference on January 30, 2008. The presentation is,expected ... All interested parties are invited to listen ... http://www.wellpoint.com and selecting the "Investor,Info" link. Following ...
... Ronit Calderon-Margalit, MD, MPH, Marianna Mazar, MD and Zvi ... Jewish and Arab diabetes sufferers who were admitted to ... whether differences existed between the two groups and, if ... health insurance coverage. The researchers found significant differences. As ...
... Jan. 25 Pizza, nachos, dip and wings ... also have one thing in common:,they can all ... counter heartburn medicine based on dollar sales, is ... tasty heartburn-friendly,alternatives., , Listen to this report ...
... Belgium have significantly advanced the discovery of a pancreatic ... beta cells. If the finding made in mice holds ... obvious target for therapeutic regeneration of beta cells in ... of the research journal Cell, a publication of Cell ...
... The North Carolina,Association of Educators (NCAE) will launch a ... at increasing awareness about good eating,habits and physical fitness ... from NCAE," is slated to run in,newspapers across North ... NCAE logo -- star in an ad campaign to,encourage ...
Cached Medicine News:Health News:FDA Will Wait for Trial Results on Vytorin 2Health News:FDA Will Wait for Trial Results on Vytorin 3Health News:WellPoint Announces Appearance at Upcoming Conference 2Health News:Elusive pancreatic progenitor cells found in mice 2Health News:NCAE Encourages Minority Youth and Their Families to 'Go-for' Health and Fitness 2
... third-generation allergy test , 3gAllergy is a ... provides quantitative determination of allergen-specific IgE at ... and lot-to-lot reproducibility. The assay delivers reliable ... you identify, monitor and manage patients with ...
... System is part of a series of modular ... ranging from 3.5 to 8.0 mm. Matching a ... system provides convenience and flexibility for the orthopaedic ... system may be customized using two of three ...
The DePuy ACE 8.0mm Cannulated Cancellous Screw incorporates TiMAX to provide superior strength, fatigue resistance and a lower modulus of elasticity when compared to similar stainless steel devices....
... The VersaNail System is a complete system ... to use with TTC fusion surgery. The ... specialists and integrates clinical research and engineering ... Because every patient is different, and because ...
Medicine Products: